Ondensatron Impurity 1

Titania-based stationary phase in separation of ondansetron and its related compounds
VáclavŽižkovský, RadimKučera, JiříKlimeš, JiříDohnal
Journal of Chromatography A Volume 1189, Issues 1–2, 2 May 2008, Pages 83-91
 
Degradation of ondansetron: Isolation and characterization impurity D ondansetron as A candidate reference standard impurity in drug
E. Kristiana, Asep Saefumillah, Emil Budianto
AIP Conference Proceedings 2242(1):040054
 
Identification, isolation and characterization of unknown impurity in Ondansetron Drug product
Hemant Madhusudan Gandhi, Nageswara Rao Gollapalli, Dr. Jaydeep Kumar D. Lilakar
International Journal of Advance Research, Ideas and Innovations in Technology (Volume 4, Issue 2) 1264-1271
 
A Validated RP-HPLC method for simultaneous trace level quantification of Glyoxal in Ondansetron Hydro chloride using chemical derivatization and UV-Detection.
Karri Visweswara Raoa , K Padmaja Reddya , k. kalyana , K.S.V.Raghavacharyulu
Karri Visweswara Rao et al. / Journal of Pharmacy Research 2012,5(12),5449-5452

Ondensatron Impurity 1 is chemically 3-((2-Bromophenyl)amino)cyclohex-2-en-1-one. Ondensatron Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Ondensatron Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ondansetron.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.